Related Experiment Videos
Ventricular wall thickness: a predictor of response to vasodilators in cardiomyopathy
Insights
Chronic vasodilator therapy improved symptoms in most patients with idiopathic cardiomyopathy. Echocardiographic findings like increased wall thickness predicted a good response, with some patients becoming asymptomatic.
Area of Science:
- Cardiology
- Internal Medicine
Background:
- Idiopathic cardiomyopathy presents a significant clinical challenge.
- Symptomatic patients often require advanced therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy of chronic adjunctive vasodilator therapy in idiopathic cardiomyopathy.
- To identify predictors of treatment response.
Main Methods:
- Assessed 14 symptomatic patients with idiopathic cardiomyopathy.
- Utilized noninvasive and invasive hemodynamic assessments.
- Analyzed echocardiographic parameters, including septal and posterior wall thickness.
Main Results:
- 13 out of 14 patients showed improvement in New York Heart Association functional class.
- Three patients achieved asymptomatic status (Class I).
- Echocardiographic findings of septal and posterior wall thickness ≥1.2 cm predicted asymptomatic outcomes.
Conclusions:
- Chronic adjunctive vasodilator therapy is effective in improving symptoms of idiopathic cardiomyopathy.
- Specific echocardiographic measurements can predict a favorable response to vasodilator therapy.
Abstract:
The effect of chronic adjunctive vasodilator therapy was assessed in 14 symptomatic patients with idiopathic cardiomyopathy. Thirteen of the 14 patients improved by one or more in the New York Heart Association functional class, one remained unchanged. Three became asymptomatic (class I). Noninvasive and invasive (hemodynamic) parameters before and after vasodilators were assessed. The echocardiographic findings of septal and posterior wall thickness of 1.2 cm or greater were the best predictors of good response in our patients who subsequently became asymptomatic.